1-4 of 4
Zihai Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype

Open Access
Joanna Pozniak, Niccolò Roda, Ewout Landeloos, Asier Antoranz, Yannick Van Herck, Amber De Visscher, Philip Georg Demaerel, Lukas Vanwynsberghe, Jeroen Declercq, Christos Gkemisis, Greet Bervoets, No-Joon Song, Ayse Bassez, Robin Browaeys, Lotte Pollaris, Francesca M. Bosisio, Veerle Boecxstaens, Yvan Saeys, Diether Lambrechts, Zihai Li, Patrick Matthys, Oliver Bechter, Jean-Christophe Marine
Journal: Cancer Discovery
Cancer Discov OF1–OF16.
https://doi.org/10.1158/2159-8290.CD-24-1208
Published: 18 June 2025
View article titled, Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype
Open the PDF for Cytotoxic NK Cells Impede Response to Checkpoint Immunotherapy in Melanoma with an Immune-Excluded Phenotype in another window
Includes: Supplementary data
Journal Articles

Tumor-Associated NK Cells Regulate Distinct CD8+ T-cell Differentiation Program in Cancer and Contribute to Resistance against Immune Checkpoint Blockers

Available to Purchase
No-Joon Song, Juan Xie, Kyeong Joo Jung, Yi Wang, Joanna Pozniak, Niccolo Roda, Jean-Christophe Marine, Brian P. Riesenberg, Hyeongseon Jeon, Anjun Ma, Nathanael Cox, Darren Wethington, Kelsi Reynolds, Tong Xiao, Anqi Li, Parker Kronen, Nicholas Denko, David P. Carbone, Qin Ma, William E. Carson, III, Bethany L. Mundy-Bosse, Christin E. Burd, Jayajit Das, Dongjun Chung, Zihai Li
Journal: Cancer Discovery
Cancer Discov OF1–OF23.
https://doi.org/10.1158/2159-8290.CD-24-1232
Published: 18 June 2025
View article titled, Tumor-Associated NK Cells Regulate Distinct CD8+ T-cell Differentiation Program in Cancer and Contribute to Resistance against Immune Checkpoint Blockers
Open the PDF for Tumor-Associated NK Cells Regulate Distinct CD8+ T-cell Differentiation Program in Cancer and Contribute to Resistance against Immune Checkpoint Blockers in another window
Includes: Supplementary data
Journal Articles

Converting Tumoral PD-L1 into a 4-1BB Agonist for Safer and More Effective Cancer Immunotherapy

Available to Purchase
Zihai Li, Joseph H. Azar, Mark P. Rubinstein
Journal: Cancer Discovery
Cancer Discov (2022) 12 (5): 1184–1186.
https://doi.org/10.1158/2159-8290.CD-22-0219
Published: 02 May 2022
View article titled, Converting Tumoral PD-L1 into a 4-1BB Agonist for Safer and More Effective Cancer Immunotherapy
Open the PDF for Converting Tumoral PD-L1 into a 4-1BB Agonist for Safer and More Effective Cancer Immunotherapy in another window
Includes: Supplementary data
Journal Articles

PRMT5 Is Required for Lymphomagenesis Triggered by Multiple Oncogenic Drivers

Free
Yan Li, Nilesh Chitnis, Hiroshi Nakagawa, Yoshiaki Kita, Shoji Natsugoe, Yi Yang, Zihai Li, Mariusz Wasik, Andres J.P. Klein-Szanto, Anil K. Rustgi, J. Alan Diehl
Journal: Cancer Discovery
Cancer Discov (2015) 5 (3): 288–303.
https://doi.org/10.1158/2159-8290.CD-14-0625
Published: 05 March 2015
View article titled, PRMT5 Is Required for Lymphomagenesis Triggered by Multiple Oncogenic Drivers
Open the PDF for PRMT5 Is Required for Lymphomagenesis Triggered by Multiple Oncogenic Drivers in another window
Includes: Supplementary data